MORETTI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 368
EU - Europa 290
AS - Asia 41
SA - Sud America 1
Totale 700
Nazione #
US - Stati Uniti d'America 367
GB - Regno Unito 94
IE - Irlanda 59
CN - Cina 36
DE - Germania 29
UA - Ucraina 29
IT - Italia 26
SE - Svezia 22
FR - Francia 12
FI - Finlandia 9
BE - Belgio 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
ES - Italia 2
JP - Giappone 2
AR - Argentina 1
CA - Canada 1
SG - Singapore 1
TR - Turchia 1
VN - Vietnam 1
Totale 700
Città #
Southend 92
Fairfield 65
Dublin 57
Ashburn 41
Seattle 33
Wilmington 31
Chandler 29
Woodbridge 25
Houston 23
Jacksonville 22
Cambridge 19
Ann Arbor 18
Siena 12
Princeton 8
Beijing 7
Nanjing 7
San Diego 7
Shanghai 5
Boardman 4
Helsinki 4
San Mateo 4
Brussels 3
Hebei 3
Jinan 3
Los Angeles 3
Shenyang 3
Venezia 3
Washington 3
Brescia 2
Brno 2
Düsseldorf 2
Hangzhou 2
Moscow 2
Málaga 2
Tianjin 2
Berlin 1
Buenos Aires 1
Changsha 1
Chicago 1
Florence 1
Guangzhou 1
Hanoi 1
Izmir 1
Jiaxing 1
Kunming 1
London 1
Montreal 1
Munich 1
Nagasawa 1
Philadelphia 1
Redmond 1
Redwood City 1
Tappahannock 1
Yokosuka 1
Totale 567
Nome #
Calpains and cancer: friends or enemies? 165
Cisplatin-induced apoptosis inhibits autophagy, which acts as a pro-survival mechanism in human melanoma cells 153
Cross-talk between calpain and caspase-3/-7 in cisplatin-induced apoptosis of melanoma cells: a major role of calpain inhibition in cell death protection and p53 status 135
Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients 133
Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-inducedchanges in vitro and differential expression in melanocytic lesions 119
Totale 705
Categoria #
all - tutte 2.118
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.118


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020179 26 7 10 32 20 13 12 19 18 9 2 11
2020/202195 5 13 4 10 5 7 6 11 13 5 11 5
2021/202272 4 15 8 3 1 1 6 7 6 7 1 13
2022/2023100 5 6 20 12 12 18 2 10 3 7 4 1
2023/202491 1 3 9 5 9 27 31 0 0 3 0 3
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 705